AMLODIPINE BESYLATE AND VALSARTAN (amlodipine besylate; valsartan) by Teva is muscle. Approved for hypertension, to lower blood pressure: in patients not adequately controlled on monotherapy (), nonfatal cardiovascular events and 8 more indications. First approved in 2015.
Drug data last refreshed 1w ago
muscle. Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.…
Worked on AMLODIPINE BESYLATE AND VALSARTAN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.